LinkedIn’s latest B2B marketing report, The Art and Science of Video Storytelling, provides a detailed look at what drives video performance in today’s attention-scarce digital landscape. Based on an analysis of over 13,000 video ads, the findings confirm a major shift in what audiences respond to – and what brands should prioritize when developing content.
Rather than production value alone, LinkedIn identifies a core set of creative principles that consistently elevate video performance:
For pharmaceutical marketers, these findings reinforce the importance of clarity, authenticity, and format-first thinking. Video is no longer optional—it’s a critical lever for brand engagement, education, and trust-building.
Key takeaways include:
LinkedIn’s report confirms what many in the pharma space have sensed: the future of brand communication isn’t just regulated – it’s also emotional, contextual, and increasingly fast-moving.
As content expectations rise and attention windows narrow, health brands must blend credibility with creativity to stay relevant.
The opportunity is clear: With the right mix of expert insight, cultural awareness, and mobile-first execution, pharma brands can deliver high-impact storytelling that informs, inspires, and earns attention.
Get the full report HERE